ADRB3
Beta-3 adrenergic receptor
Also known as: ADRB3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P13945
- Gene
- ADRB3
- Ensembl
- ENSG00000188778
- Chromosome
- 8
- Canonical length
- 408 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins
- Subcellular location
- Basal body
OverviewNCBI Gene
The protein encoded by this gene belongs to the family of beta adrenergic receptors, which mediate catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor is located mainly in the adipose tissue and is involved in the regulation of lipolysis and thermogenesis. Obesity and bodyweight-related disorders are correlated with certain polymorphisms in three subtypes of beta-adrenoceptor, among them, the ADRB3 gene.[provided by RefSeq, Oct 2019]
Canonical amino-acid sequenceUniProt
408 residues, UniProt reviewed canonical sequence.
>P13945|ADRB3
1 MAPWPHENSS LAPWPDLPTL APNTANTSGL PGVPWEAALA GALLALAVLA TVGGNLLVIV
61 AIAWTPRLQT MTNVFVTSLA AADLVMGLLV VPPAATLALT GHWPLGATGC ELWTSVDVLC
121 VTASIETLCA LAVDRYLAVT NPLRYGALVT KRCARTAVVL VWVVSAAVSF APIMSQWWRV
181 GADAEAQRCH SNPRCCAFAS NMPYVLLSSS VSFYLPLLVM LFVYARVFVV ATRQLRLLRG
241 ELGRFPPEES PPAPSRSLAP APVGTCAPPE GVPACGRRPA RLLPLREHRA LCTLGLIMGT
301 FTLCWLPFFL ANVLRALGGP SLVPGPAFLA LNWLGYANSA FNPLIYCRSP DFRSAFRRLL
361 CRCGRRLPPE PCAAARPALF PSGVPAARSS PAQPRLCQRL DGASWGVSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADRB3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- ovary: 13 nTPM
- fallopian tube: 5.3 nTPM
- urinary bladder: 5.2 nTPM
- placenta: 2.7 nTPM
- colon: 2.3 nTPM
- stomach: 2.3 nTPM
Single-cell type
- smooth muscle cells: 0.2 nCPM
- adipocytes: 0.1 nCPM
- distal convoluted tubule cells: 0.1 nCPM
- fibroblasts: 0.1 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
Immune cell
- basophil: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- medulla oblongata: 15 nTPM
- pons: 6.3 nTPM
- thalamus: 4.5 nTPM
- choroid plexus: 3.9 nTPM
- midbrain: 3.5 nTPM
- basal ganglia: 3 nTPM
ReferencesPubMed · IEDB
Publications for ADRB3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- [Cardiovascular effects of beta1 and beta3-adrenergic receptor autoantibodies in Lewis rat].
2014 · Ann Cardiol Angeiol (Paris) · RCR 0.1 · 2 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.68
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating adrenergic receptor signaling pathway
- adenylate cyclase-inhibiting adrenergic receptor signaling pathway
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- adenylate cyclase-modulating G protein-coupled receptor signaling pathway
- brown fat cell differentiation
- carbohydrate metabolic process
- diet induced thermogenesis
- eating behavior
- energy reserve metabolic process
- G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
- generation of precursor metabolites and energy
- heat generation
- negative regulation of cardiac muscle contraction
- negative regulation of multicellular organism growth
- negative regulation of smooth muscle contraction
- norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure
- positive regulation of cold-induced thermogenesis
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of lipid catabolic process
- positive regulation of MAPK cascade
- response to cold
Molecular functions
- beta-3 adrenergic receptor binding
- beta-adrenergic receptor activity
- epinephrine binding
- G protein activity
- norepinephrine binding
- protein homodimerization activity
- beta3-adrenergic receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADRB3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADRB3 as an antibody target. Whether an autoantibody or antibody against ADRB3 could matter depends on whether native ADRB3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADRB3 is annotated at the cell surface, where native ADRB3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADRB3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...